A detailed history of Charles Schwab Investment Management Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,222,850 shares of PGEN stock, worth $917,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,222,850
Previous 1,095,383 11.64%
Holding current value
$917,137
Previous $1.73 Million 32.89%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.91 - $1.88 $115,994 - $239,637
127,467 Added 11.64%
1,222,850 $1.16 Million
Q2 2024

Aug 12, 2024

BUY
$1.27 - $1.75 $34,107 - $46,998
26,856 Added 2.51%
1,095,383 $1.73 Million
Q1 2024

May 08, 2024

BUY
$1.21 - $1.75 $71,521 - $103,440
59,109 Added 5.86%
1,068,527 $1.55 Million
Q4 2023

Feb 06, 2024

SELL
$0.89 - $1.41 $45,480 - $72,053
-51,102 Reduced 4.82%
1,009,418 $1.35 Million
Q3 2023

Nov 08, 2023

SELL
$1.08 - $1.85 $40,131 - $68,744
-37,159 Reduced 3.39%
1,060,520 $1.51 Million
Q2 2023

Aug 09, 2023

BUY
$0.96 - $1.4 $60,557 - $88,313
63,081 Added 6.1%
1,097,679 $1.26 Million
Q1 2023

May 11, 2023

BUY
$0.88 - $2.19 $243,906 - $606,993
277,166 Added 36.59%
1,034,598 $1.1 Million
Q4 2022

Feb 13, 2023

BUY
$1.27 - $2.26 $13,851 - $24,649
10,907 Added 1.46%
757,432 $1.15 Million
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $109,558 - $216,785
77,701 Added 11.62%
746,525 $1.58 Million
Q2 2022

Aug 15, 2022

SELL
$1.15 - $2.53 $62,461 - $137,414
-54,314 Reduced 7.51%
668,824 $897,000
Q1 2022

May 13, 2022

SELL
$1.91 - $3.98 $58,382 - $121,656
-30,567 Reduced 4.06%
723,138 $1.53 Million
Q4 2021

Feb 11, 2022

BUY
$3.53 - $5.5 $54,224 - $84,485
15,361 Added 2.08%
753,705 $2.8 Million
Q3 2021

Nov 16, 2021

BUY
$4.99 - $6.55 $61,945 - $81,311
12,414 Added 1.71%
738,344 $3.69 Million
Q2 2021

Aug 16, 2021

BUY
$6.24 - $8.22 $889,742 - $1.17 Million
142,587 Added 24.44%
725,930 $4.73 Million
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $781,381 - $1.27 Million
115,932 Added 24.8%
583,343 $4.02 Million
Q4 2020

Feb 16, 2021

BUY
$3.75 - $10.56 $54,513 - $153,510
14,537 Added 3.21%
467,411 $4.77 Million
Q3 2020

Nov 13, 2020

BUY
$3.5 - $6.2 $2,628 - $4,656
751 Added 0.17%
452,874 $1.59 Million
Q2 2020

Aug 14, 2020

BUY
$2.16 - $5.46 $10,672 - $26,977
4,941 Added 1.1%
452,123 $2.26 Million
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $652,885 - $3.22 Million
447,182 New
447,182 $1.52 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.